EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Outcomes of transfemoral TAVR using two new‐generation devices in patients with horizontal aorta

Clemens Eckel iD, Won-Keun Kim iD, Botros Wasif, Christina Grothusen, Albrecht Elsässer, Guido Dohmen, Efstratios I Charitos, Samuel Sossalla, Helge Möllmann, Johannes Blumenstein iD

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.31094 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Clemens Eckel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, St. Johannes Hospital, Dortmund, Germany. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Heart Valve Prosthesis, Prosthesis Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Challenging anatomies and comorbidities have impact on success in transcatheter aortic valve replacement (TAVR). There is controversy whether the extent of the aortic angle (AA) has an impact on procedural outcomes. Matched comparative outcome data of new generation transcatheter heart valves (THVs) in horizontal aorta (HA) are scarce.

Methods

A total of 1582 patients with severe native aortic stenosis (AS) treated with the SAPIEN3 Ultra (Ultra; n = 526) or ACURATE Neo2 (Neo2; n = 1056) THVs from January 2017 to January 2023 were analyzed. Patients with non‐horizontal aortas (AA < 51.7°, n = 841) were excluded. The population was matched by 1‐to‐1 nearest‐neighbor matching (Ultra, n = 246; Neo2, n = 246). Clinical and procedural outcome were evaluated according to VARC‐3 recommendations.

Results

Technical success (93.1% vs. 94.7%, p = 0.572) was high after Ultra and Neo2. Device success (80.5% vs. 89.8%, p = 0.05) was inferior with Ultra. Neo2 reveals superior hemodynamic properties with lower rate of severe prosthesis patient mismatch (12.0% vs. 3.7%, p = 0.001) and elevated gradients (20 mmHg: 11.9% vs. 1.7%, p < 0.001). Ultra showed a lower rate of relevant paravalvular regurgitation (mild paravalvular regurgitation or Valve‐in‐Valve due to paravalvular regurgitation: 0.0% vs. 3.7%, p = 0.004). The rate of procedural bailout maneuvers (0.8% vs. 0.4%, p = 1.000) and thirty‐day all‐cause mortality (1.3% vs. 2.2%, p = 0.496) was similar.

Conclusion

Transfemoral TAVR in patients with severe aortic stenosis and HA, using the balloon expandable Sapien3 Ultra and self‐expanding ACURATE Neo2 prosthesis, is feasible and safe. Therefore, valve selection between these platforms should be made irrespective of the aortic angle by a team experienced with both valves based on their specific advantages. Large, randomized trials in this sub‐group of patients would be necessary to compare long term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementAortic Valve StenosisHeart Valve ProsthesisProsthesis DesignAortic ValveFemoral ArteryHemodynamicsSeverity of Illness IndexHumansFemaleTreatment OutcomeMaleAged, 80 and overAgedTime FactorsRisk FactorsRetrospective StudiesCatheterization, PeripheralRecovery of FunctionPunctures

Stichwörter der Autor:innen

AcurateNeo2SapienTAVRhorizontal aortaultra

Autor:innen und Institutionen

  • Department of Cardiology, St. Johannes Hospital, Dortmund, Germany.
  • Carl von Ossietzky Universität Oldenburg, School VI, School of Medicine and Health Sciences, Oldenburg, Germany.
  • Department of Cardiology, Kerckhoff Heart Center, Bad Nauheim, Germany.
  • Department of Cardiac Surgery, Kerckhoff Heart Center, Bad Nauheim, Germany.
  • Department of Cardiac Surgery, University of Kiel, Kiel, Germany.
  • Department of Cardiac Surgery, St. Johannes Hospital, Dortmund, Germany.

ORCID-Profile: Clemens Eckel, Won-Keun Kim, Johannes Blumenstein

Zitieren

APA

Eckel, C., Kim, W. K., Wasif, B., Grothusen, C., Elsässer, A., Dohmen, G., Charitos, E. I., Sossalla, S., Möllmann, H., & Blumenstein, J. (2024). Outcomes of transfemoral TAVR using two new‐generation devices in patients with horizontal aorta. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31094

Vancouver

Eckel C, Kim WK, Wasif B, Grothusen C, Elsässer A, Dohmen G, et al. Outcomes of transfemoral TAVR using two new‐generation devices in patients with horizontal aorta. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31094

BibTeX
@article{Eckel2024,
  author = {Eckel, Clemens and Kim, Won-Keun and Wasif, Botros and Grothusen, Christina and Elsässer, Albrecht and Dohmen, Guido and Charitos, Efstratios I and Sossalla, Samuel and Möllmann, Helge and Blumenstein, Johannes},
  title = {Outcomes of transfemoral TAVR using two new‐generation devices in patients with horizontal aorta},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.31094}
}
Kostenlos starten →